- Retail Offer
- Acquisition, Fundraising and Change of Name
- SFX-01 positive update in bowel cancer models
- Positive update on SFX-01 in vitro GBM studies
- Notice of Dispute lodged with Stalicla SA
- Series B Fund Raise by partner, Stalicla SA
- Holding(s) in Company
- Directorate Changes
- Upcoming conferences
- Half-year Report
More ▼
Key statistics
On Thursday, Evgen Pharma PLC (EVG:LSE) closed at 0.875, 8.02% above its 52-week low of 0.81, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.875 |
---|---|
High | 1.00 |
Low | 1.00 |
Bid | 0.80 |
Offer | 1.10 |
Previous close | 0.875 |
Average volume | 960.94k |
---|---|
Shares outstanding | 274.89m |
Free float | 164.08m |
P/E (TTM) | -- |
Market cap | 2.41m GBP |
EPS (TTM) | -0.0122 GBP |
Data delayed at least 20 minutes, as of Mar 28 2024 16:25 BST.
More ▼